|
1
| 2
| 3 | 4
| 5
References
1. Botvin GJ, Baker E, Dusenbury L, Botvin EM, Diaz
T. Long-term follow-up results of a randomized drug abuse prevention
trial in a white middle-class population. JAMA 1995;273:1106–12.
2. Beardslee WR, Versage EM, Wright EJ, Salt P, Rothberg PC, Drezner
K, Gladstone TR. Examination of preventive interventions for families
with depression: evidence of change. Dev Psychopathol 1997;9:109–30.
3. Clarke G. Prevention of depression in at-risk samples of adolescents.
In: Essau C, Petermann F, edtors. Depressive disorders in children
and adolescents: epidemiology, risk factors, and treatment. Northvale
(NJ): Jason Aronson, Inc; 1999. p 341–60.
4. Olds D, Henderson CR Jr, Cole R, Eckenrode J, Kitzman H, Luckey
D, and others. Long-term effects of nurse home visitation on children’s
criminal and antisocial behavior: 15-year follow-up of a randomized
controlled trial. JAMA 1998;80:1238–44.
5. Dolan L, Kellam S, Brown C, Werthamer-Larsson L, Rebok G, Mayer
L, and others. The short-term impact of two classroom based preventive
intervention trials on aggressive and shy behaviors and poor achievement.
Journal of Applied Developmental Psychology 1993;14:317–45.
6. Ialongo NS, Werthamer L, Kellam SG, Brown CH, Wang S, Lin Y.
Proximal impact of two first-grade preventive interventions on the
early risk behaviors for later substance abuse, depression, and
antisocial behavior. Am J Community Psychol 1999;27:599–641.
7. Reid JB, Eddy JM, Fetrow RA, Stoolmiller M. Description and immediate
impacts of a preventive intervention for conduct problems. Am J
Community Psychol 1999;27:483–517.
8. Conduct Problems Prevention Research Group. A developmental and
clinical model for the prevention of conduct disorder: The FAST
track program. Dev Psychopathol 1992;4:509–27.
9. Coie JD, Watt NF, West SG, Hawkins JD, Asarnow JR, Markman HJ,
and others. The science of prevention. A conceptual framework and
some directions for a national research program. Am Psychol 1993;48:1013–22.
10. Kraemer HC, Kazdin AE, Offord DR, Kessler RC, Jensen PS, Kupfer
DJ. Coming to terms with the terms of risk. Arch Gen Psychiatry
1997;54:337–43.
11. Goldstein JM. The impact of gender on understanding the epidemiology
of schizophrenia. In: Seeman MV, editor. Gender and psychopathology.
Washington (DC): American Psychiatric Association Press; 1995. p
159–99.
12. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel
DE, Gaskell PC Jr, and others. Protective effect of apolipoprotein
E type 2 allele for late onset Alzheimer disease. Nat Genet 1994;7:180–4.
13. Tsuang MT, Faraone SV. The case for heterogeneity in the etiology
of schizophrenia. Schizophr Res 1995;17:161–75.
14. Reiss D, Hetherington EM, Plomin R, Howe GW, Simmens SJ, Henderson
SH, and others. Genetic questions for environmental studies. Differential
parenting and psychopathology in adolescence. Arch Gen Psychiatry
1995;52:925–36.
15. Reiss D, Plomin R, Hetherington EM. Genetics and psychiatry:
an unheralded window on the environment. Am J Psychiatry 1991;148:283–91.
16. Thomas JC, Clark M, Robinson J, Monnett M, Kilmarx PH, Peterman
TA. The social ecology of syphilis. Soc Sci Med 1999;48:1081–94.
17. Goldstein M. The UCLA high-risk project. Schizophr Bull 1987;13:505–14.
18. Faraone SV, Green AI, Seidman LJ, Tsuang MT: “Schizotaxia”:
clinical Implications and new directions for research. Schizophr
Bull 2001;27:1–18.
19. Gottesman II: Schizophrenia genesis: the origin of madness.
New York: Freeman; 1991.
20. Tsuang MT, Faraone SV. Schizophrenia. In: Winokur G, Clayton
P, editors. Medical basis of psychiatry. 2nd ed. Philadelphia (PA):
WB Saunders; 1994. p 87–114.
21. Tsuang MT, Faraone SV. Epidemiology and behavioral genetics
of schizophrenia. In: Watson SJ, editor. Biology of schizophrenia
and affective disease. New York: Raven Press; 1994. p 163–95.
22. Kendler KS. Overview: a current perspective on twin studies
of schizophrenia. Am J Psychiatry 1983;140:1413–25.
23. Kety SS, Rosenthal D, Wender PH, Schulsinger F. The types and
prevalence of mental illness in the biological and adoptive families
of adopted schizophrenics. J Psychiatr Res 1968;1 (Suppl):345–62.
24. Kety SS, Wender PH, Jacobsen B, Ingraham LJ, Jansson L, Faber
B, and others. Mental illness in the biological and adoptive relatives
of schizophrenic adoptees. Replication of the Copenhagen study in
the rest of Denmark. Arch Gen Psychiatry 1994;51:442–55.
25. Tsuang MT, Faraone SV. The frustrating search for schizophrenia
genes. Am J Med Genet 2000;97:1–3.
26. Faraone SV, Tsuang MT. Quantitative models of the genetic transmission
of schizophrenia. Psychol Bull 1985;98:41–66.
27. Risch N. Linkage strategies for genetically complex traits.
I. Multilocus models. Am J Hum Genet 1990;46:222–8.
28. Tsuang MT, Faraone SV, Green AI. Schizophrenia and other psychotic
disorders. In: Armand M, Nicholi J, editors. The Harvard guide to
psychiatry. Cambridge (MA): Harvard University Press; 1999.
29. Tsuang MT, Stone WS, Faraone SV. Schizophrenia: a review of
genetic studies. Harv Rev Psychiatry 1999;7:185–207.
30. Williams J, Spurlock G, McGuffin P, Mallet J, Nothen MM, Gill
M, and others. Association between schizophrenia and T102C polymorphism
of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre
Association Study of Schizophrenia (EMASS) Group. Lancet 1996;347:1294–6.
31. Williams J, McGuffin P, Nothen M, Owen MJ. Meta-analysis of
association between the 5-HT2a receptor T102C polymorphism and schizophrenia.
EMASS Collaborative Group. European Multicentre Association Study
of Schizophrenia. Lancet 1997;349:1221.
32. Dubertret C, Gorwood P, Ades J, Feingold J, Schwartz JC, Sokoloff
P. Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity
and significant association in Caucasians. Am J Med Genet 1998;81:318–22.
33. Williams J, Spurlock G, Holmans P, Mant R, Murphy K, Jones L,
and others. A meta-analysis and transmission disequilibrium study
of association between the dopamine D3 receptor gene and schizophrenia.
Mol Psychiatry 1998;3:141–9.
34. Arinami T, Itokawa M, Enguchi H, Tagaya H, Yano S, Shimizu H,
and others. Association of dopamine D2 receptor molecular variant
with schizophrenia. Lancet 1994;343:703–4.
35. Kinney DK, Holzman PS, Jacobsen B, Jansson L, Faber B, Hildebrand
W. Thought disorder in schizophrenic and control adoptees and their
relatives. Arch Gen Psychiatry 1997;54:475–9.
36. Tienari PJ, Wynne LC. Adoption studies of schizophrenia. Ann
Med 1994;26:233–7.
37. Tienari P. Interaction between genetic vulnerability and family
environment: The Finnish adoptive family study of schizophrenia.
Acta Psychiatr Scand 1991;84:460–5.
38. Wahlberg K-E, Wynne LC, Oja H, Keskitalo P, Pykalainen L, Lahti
I, and others. Gene-environment interaction in vulnerability to
schizophrenia: findings from the Finnish adoptive family study in
schizophrenia. Am J Psychiatry 1997;154:355–62.
39. Tienari P, Wynne LC, Moring J, Lahti I, Naarala M, Sorri A,
and others. The Finnish adoptive family study of schizophrenia.
Implications for family research. Br J Psychiatry 1994;163 (Suppl
23):20–6.
40. Lane EA, Albee GW. Comparative birthweights of schizophrenics
and their siblings. J Psychol 1966;64:227.
41. Woerner MG, Pollack M, Klein DF. Birthweight and length in schizophrenics,
personality disorders and their siblings. Br J Psychiatry 1971;118:461.
42. Jacobsen B, Kinney DK. Perinatal complications in adopted and
non-adopted schizophrenics and thier controls: preliminary results.
Acta Psychiatr Scand 1980;Suppl 285:337.
43. McNeil TF, Kaij L. Obstetric factors in the development of schizophrenia:
complications in the births of preschizophrenics and in reproduction
by schizophrenic parents. In: Wynne LC, Cromwell RL, Matthysse S,
editors. The nature of schizophrenia. New approaches to research
and treatment. New York: John Wiley and Sons; 1978. p 401–29.
44. McNeil TF. Obstetric factors and perinatal injuries. In: Tsuang
MT, Simpson JC, editors. Nosology, epidemiology and genetics of
schizophrenia. Volume 3. New York: Elsevier; 1988. p 319–44.
45. Buka SK, Goldstein JM, Seidman LJ, Zornberg GL, Donatelli JA,
Denny LR, and others. Prenatal complications, genetic vulnerability,
and schizophrenia: the New England longitudinal studies of schizophrenia.
Psychiatric Annals 1999;29:151–6.
46. Buka SL, Tsuang MT, Lipsitt LP. Pregnancy/delivery complications
and psychiatric diagnosis. A prospective study. Arch Gen Psychiatry
1993;50:151–6.
47. Cannon TD, Mednick SA, Parnas J. Genetic and perinatal determinants
of structural brain deficits in schizophrenia. Arch Gen Psychiatry
1989;46:883–9.
48.Zornberg GL, Buka SL, Tsuang MT. Hypoxic-ischemia-related fetal/neonatal
complications and risk of schizophrenia and other nonaffective psychoses:
a 19-year longitudinal study. Am J Psychiatry 2000;157:196–202.
49. Kinney DK, Jacobsen S. Environmental factors in schizophrenia:
New adoption evidence. In: Wynne LC, Cromwell RL, Matthysse S. The
nature of schizophenia: new approaches to research and treatment.
New York: John Wiley and Sons; 1978. p 38–51.
50. O’Callaghan E, Larkin C, Kinsella A, Waddington JL. Obstetric
complications, the putative familial-sporadic distinction, and tardive
dyskinesia in schizophrenia. Br J Psychiatry 1990;157:578–84.
51. Reveley AM, Reveley MA, Murray RM. Cerebral ventricular enlargement
in non-genetic schizophrenia: a controlled twin study. Br J Psychiatry
1984;144:89–93.
52. Schwarzkopf SB, Nasrallah HA, Olson SC, Coffman JA, McLaughlin
JA. Preinatal complications and genetic loading in schizophrenia:
preliminary findings. Psychiatry Res 1989;27:233–9.
53. McNeil TF, Cantor-Graae E, Torrey EF, Sjostrom K, Bowler A,
Taylor E, and others. Obstetric complications in histories of monozygotic
twins discordant and concordant for schizophrenia. Acta Psychiatr
Scand 1994;89:196–204.
54. Onstad S, Skre I, Torgersen S, Kringlen E. Birthweight and obstetric
complications in schizophrenic twins. Acta Psychiatr Scand 1992;85:487–93.
55. Pollin W, Stabenau JR. Biological, psychological and historical
differences in a series of monozygotic twins discordant for schizophrenia.
In: Rosenthal D, Kety S, editors. The transmission of schizophrenia.
New York: Pergamon Press; 1968.
56. Shields J, Gottesman II. Obstetric complications and twin studies
of schizophrenia: clarification and affirmation. Schizophr Bull
1977;3:351–4.
57. DeLisi LE, Dauphinais ID, Gershon ES. Perinatal complications
and reduced size of brain limbic structures in familial schizophrenia.
Schizophr Bull 1988;14:185–91.
58. Mednick SA. Breakdown in individuals at high risk for schizophenia:
possible predispositional perinatal factors. Mental Hygiene 1970;54:50.
59. Parnas J, Schulsinger F, Teasdale TW, Feldman PM, Mednick SA.
Preinatal complications and clinical outcome within the schizophrenia
spectrum. Br J Psychiatry 1982;140:416.
60. Torrey EF, Kaufmann CA. Schizophrenia and neuroviruses. In:
Nasrallah HA, Weinberger DR, editors. The neurology of schizophrenia.
Volume 1. Amsterdam, New York, Oxford: Elsevier Science Publishers
BV; 1986. p 361–76.
61. Dalen P. Season of birth - a study of schizophrenia and other
mental disorders. Amsterdam: Elsevier; 1975.
62. Hare E, Price J, Slater E. Mental disorder and season of birth.
Br J Psychiatry 1974;124:81.
63. Hare E. The season of birth of siblings of psychiatric patients.
Br J Psychiatry 1976;129:49.
64. Ganguli R, Rabin BS, Kelly RH, Lyte M, Ragu U. Clinical and
laboratory evidence of autoimmunity in acute schizophrenia. Ann
N Y Acad Sci 1987;496:676–85.
65. Kaufmann CA, Weinberger Dr, Yolken RH, Torrey EF, Potkin SF.
Viruses and schizophrenia. Lancet 1983;2:1136–7.
66. Kirch DG, Kaurmann CA, Papadopoulous NM, Martin B, Weinberger
DR. Abnormal cerebrospinal fluid indices in schizophrenia. Biol
Psychiatry 1985;20:1039–46.
67. Libikova H, Breir S, Kosikova M, Pagady J, Stunzer D, Ujhazyova
D. Assay of interferon and viral antibodies in the cerebrospinal
fluid in clinical neurology and psychiatry. Acta Biologica Medica
Germanica 1979;38:879–93.
68. Rapaport MH, McAllister CG, Pickar D, Nelson DL, Paul SM. Elevated
levels of soluble interleukin 2 receptors in schizophrenia. Arch
Gen Psychiatry 1989;46:291–2.
69. Torrey EF, Yolken RH, Winfrey CJ. Cytomegalovirus antibody in
cerebrospinal fluid of schizophrenic patients detected by enzyme
immunoassay. Science 1982;216:892–3.
70. van Kammen DP, Mann L, Scheinin M, van Kammen WB, Linnoila M.
Spinal fluid monoamine metabolites and anti-cytomegalovirus antibodies
and brain scan evaluation in schizophrenia. Psychopharmacol Bull
1984;20:519–22.
71. Goldin LR, DeLisi LE, Gershon ES. Genetic aspects to the biology
of schizophrenia. In: Henn FA, DeLisi LE, editors. Neurochemistry
and neuropharmacology of schizophrenia. Volume 2.Amsterdam, New
York, Oxford: Elsevier; 1987. p 467–87.
72. Wright J, Gill M, Murray RM. Schizophrenia: genetics and the
maternal immune response to viral infection. Am J Med Genet 1993;48:40–6.
73. Mednick SA, Machon RA, Huttunen MO, Bonett D. Adult schizophrenia
following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry
1988;45:189–92.
74. Kendell RE, Kemp JW. Maternal influenza in the etiology of schizophrenia.
Arch Gen Psychiatry 1989;46:878–82.
75. Torrey EF, Rawlings R, Waldman IN. Schizophrenic births and
viral diseases in two states. Schizophr Res 1988;1:73–7.
76. Barr CE, Mednick SA, Munk-Jorgensen P. Exposure to influenza
epidemics during gestation and adult schizophrenia. A 40-year study.
Arch Gen Psychiatry 1990;47:869–74.
77. Takei N, Sham P, O’Callaghan E, Murray GK, Glover G, Murray
RM. Prenatal influenza and schizophrenia: is the effect confined
to females? Am J Psychiatry 1994;151:117–9.
78. Sham PC, O’Callaghan E, Takei N, Murray GK, Hare EH, Murray
RM. Schizophrenia following prenatal exposure to influenza epidemics
between 1939 and 1960. Br J Psychiatry 1992;160:461–6.
79. Crow TJ, Done DJ. Prenatal exposure to influenza does not cause
schizophrenia. Br J Psychiatry 1992;161:390–3.
80. Goldstein JM, Santangelo SL, Simpson JC, Tsuang MT. The role
of gender in identifying subtypes of schizophrenia: a latent class
analytic approach. Schizophr Bull 1990;16:263–75.
81. O’Callaghan E, Gibson T, Colohan HA, Walshe D, Buckley
P, Larkin C, and others. Season of birth in schizophrenia. Evidence
for confinement of an excess of winter births to patients without
a family history of mental disorder. Br J Psychiatry 1991;158:764–9.
82. Roy M-A, Flaum MA, Gupta S, Jaramillo L, Andreasen NC. Epidemiological
and clinical correlates of familial and sporadic schizophrenia.
Acta Psychiatr Scand 1994;89:324–8.
83. Shur E. Season of birth in high and low genetic risk schizophrenics.
Br J Psychiatry 1982;140:410–5.
84. Pulver AE, Liang K-Y, Brown CH, Wolyniec P, McGrath J, Adler
L, and others. Risk factors in schizophrenia season of birth, gender,
and familial risk. Br J Psychiatry 1992;160:65–71.
85. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Wagner RL, Yolken
RH. Maternal cytokine levels during pregnancy and adult psychosis.
Brain Behav Immun 2001;15:411–20.
86. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Bernstein D, Yolken
RH. Maternal infections and subsequent psychosis among offspring.
Arch Gen Psychiatry 2001;58:1032–7.
87. Wolchik SA, West SG, Sandler IN, Tein JY, Coatsworth D, Lengua
L, and others. An experimental evaluation of theory-based mother
and mother-child programs for children of divorce. J Consult Clin
Psychol 2000;68:843–56.
88. Sandler IN, Tein JY, West SG. Coping, stress, and the psychological
symptoms of children of divorce: a cross-sectional and longitudinal
study. Child Dev 1994;65:1744–63.
89. Vinokur AD, Schul Y, Vuori J, Price RH. Two years after a job
loss: long-term impact of the JOBS program on reemployment and mental
health. J Occup Health Psychol 2000;5(1):32–47.
90. Gainey RR, Catalano RF, Haggerty KP, Hoppe MJ. Participation
in a parent training program for methadone clients. Addict Behav
1995;20:117–25.
91. Tsuang MT, Stone WS, Faraone SV. Towards the prevention of schizophrenia.
Biol Psychiatry 2000;48:349–56.
92. Fish B, Marcus J, Hans SL, Auerbach JG, Perdue S. Infants at
risk for schizophrenia: sequelae of a genetic neurointegrative defect.
A review and replication analysis of pandysmaturation in the Jerusalem
infant development study. Arch Gen Psychiatry 1992;49:221–35.
93. Olin S-cS, Mednick SA. Risk factors of psychosis: Identifying
vulnerable populations premorbidly. Schizophr Bull 1996;22:223–40.
94. Erlenmeyer-Kimling L. Personal communication, 1997.
95. Walker E, Lewine RJ. Prediction of adult-onset schizophrenia
from childhood home movies of the parents. Am J Psychiatry 1990;147:1052–6.
96. Hans SL, Marcus J, Henson L, Auerbach JG, Mirsky AF. Interpersonal
behavior of children at risk for schizophrenia. Psychiatry 1992;55:314–35.
97. Faraone SV, Tsuang MT. Measuring diagnostic accuracy in the
absence of a gold standard. Am J Psychiatry 1994;151:650–7.
98. Pulver AE, Karayiorgou M, Wolyneic P, Lasseter VK, Kasch L,
Nestadt G, and others. Sequential strategy to identify a susceptibility
gene for schizophrenia: report of potential linkage on on chromosome
22q12-q13.1. Part 1. Am J Med Genet 1994;54:36–43.
99. Schizophrenia Collaborative Linkage Group (Chromosome 22). A
combined analysis of D22S278 marker alleles in affected sib-pairs:
support for a susceptibility locus at chromosomen 22q12. Am J Med
Genet 1996;67:40–5.
100. Wang S, Sun CE, Walczak CA, Ziegle JS, Kipps BR, Goldin LR,
and others. Evidence for a susceptibility locus for schizophrenia
on chromosome 6pter-p22. Nature Genetics 1995;10:41–6.
101. Straub RE, MacLean CJ, O’Neill FA, Burke J, Murphy B,
Duke F, and others. A potential vulnerability locus for schizophrenia
on chromosome 6p24-22: evidence for genetic heterogeneity. Nature
Genetics 1995;287–93.
102. Schizophrenia Linkage Collaborative Group for Chromosomes 3
6 and 8. Additional support for schizophrenia linkage on chromosomes
6 and 8: a multicenter study. Am J Med Genet 1996;67:580–94.
103. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olingy
A, Davis A, and others. Linkage of a neurophysiological deficit
in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci 1997;94:587–92.
104. Leonard S, Gault J, Moore T, Hopkins J, Tobinsion M, Olincy
A, and others. Further investigation of a chromosome 15 locus in
schizophrenia: analysis of affected sibpairs from the NIMH Genetics
Initiative. Am J Medl Genet 1998;81:308–12.
105. Schwab SG, Hallmayer J, Albus M, Lerer B, Hanses C, Kanyas
K, and others. Further evidence for a susceptibility locus on chromosome
10p14-p11 in 72 families with schizophrenia by non-parametric linkage
analysis. Am J Med Genet 1998;81:302–7.
106. Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Suarez
B, and others . Genome scan of European-American schizophrenia pedigrees:
results of the NIMH Genetics Initiative and Millennium Consortium.
Am J Med Genet 1998;81:290–5.
107. Straub RE, MacLean CJ, Martin RB, Ma Y, Myakishev MV, Harris-Kerr
C, and others. A schizophrenia locus may be located in region 10p15-p11.
Am J Med Genet 1998;81:296–301.
108. Mrazek P, Haggerty R. Reducing risks for mental disorders:
frontiers for preventive intervention research. Washington (DC):
National Academy of Sciences, Institute of Medicine; 1994.
109. Wyatt RJ. Early intervention for schizophrenia: can the course
of the illness be altered? Biol Psychiatry 1995;38:1–3.
110. McGlashan TH, Johannessen JO. Early detection and intervention
with schizophrenia: rationale. Schizophr Bull 1996;22:201–22.
111. Lieberman JA. Atypical antipsychotic drugs as a first-line
treatment of schizophrenia: a rationale and hypothesis. J Clin Psychiatry
1996;57 (Suppl 11):68–71.
112. McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson
HJ: EPPIC. An evolving system of early detection and optimal management.
Schizophr Bull 1996;22:305–26.
113. Vaglum P. Earlier detection and intervention in schizophrenia:
unsolved questions. Schizophr Bull 1996;22:347–52.
114. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar
A. Monitoring and care of young people at incipient risk of psychosis.
Schizophr Bull 1996;22:283–304.
115. Falloon IRH, Kydd RR, Coverdale JH, Laidlaw TM. Early detection
and intervention for initial episodes of schizophrenia. Schizophr
Bull 1996;22:271–82.
116. Green AI, Schildkraut JJ. Should clozapine be a first-line
treatment for schizophrenia? The rationale for a double-blind clinical
trial in first-episode patients. Harv Rev Psychiatry 1995;3:1–9.
117. McGlashan TH. Early detection and intervention in schizophrenia:
research. Schizophr Bull 1996;22:327–45.
118. Costello E, Angold A. Developmental epidemiology: a framework
for developmental psychopathology. In: Sameroff A, Lewis M, Miller
S, editors. Handbook of developmental psychopathology. New York:
Kluwer Academic/Plenum Publishers; 2000. p 57–73.
119. Mirsky AF, Kugelmass S, Ingraham LJ, Frenkel E, Nathan M. Overview
and summary: twenty-five-year followup of high-risk children. Schizophr
Bull 1995;21:227–39.
120. Kellam SG, Ling X, Merisca R, Brown CH, Ialongo N. The effect
of the level of aggression in the first grade classroom on the course
and malleability of aggressive behavior into middle school. Dev
Psychopathol 1998;10:165–85.
121. Holzer C, Shea B, Swanson J, Leaf P. The increased risk for
specific psychiatric disorders among persons of low socioeconomic
status. Am J Soc Psychiatry 1986;6;259–71.
122. Erlenmeyer-Kimling L, Rock D, Roberts SA, Janal M, Kestenbaum
C, Cornblatt B, and others. Attention, memory, and motor skills
as childhood predictors of schizophrenia-related psychoses: the
NewYork High Risk Project. Am J Psychiatry 2000; 157:1416–22.
123. Muthen B, Curran P. General longitudinal modeling of individual
differences in experimental designs: A latent variable framework
for analysis and power estimation. Psychol Methods 1997;2:371–402.
124. Brown CH, Liao J. Principles for designing randomized preventive
trials in mental health: an emerging developmental epidemiology
paradigm. Am J Community Psychol 1999;27:673–710.
125. Hawkins J, Lishner D, Catalano R. Childhood predictors and
the prevention of adolescent substance abuse. NIDA Res Monogr 1985;56:75–126.
126. Rebok G, Smith C, Pascualvaca D, Mirsky A, Anthony B, Kellam
S. Developmental changes in attentional performance in urban children
from eight to thirteen years. Child Neuropsychology 1997;3:28–46.
127. Lorion R. Basing preventive interventions on theory: stimulating
a field’s momentum. Prevention in Human Services 1989;7:7–31.
128. Cornblatt B, Obuchowski M, Schnur D, O’Brien JD. Hillside
study of risk and early detection in schizophrenia. Br J Psychiatry
Suppl 1998;172:26–32.
--------------------------------------------------------------------------------
Manuscript received and accepted June 2002.
1 Associate Professor, Department of Psychiatry, Harvard Medical
School, Massachusetts General Hospital Boston, Massachusetts; Chief
of Psychiatric Genetics, Harvard Institute of Psychiatric Epidemiology
and Genetics, Boston, Massachusetts.
2 Director, Biostastistics and Epidemiology Center for Health Research,
University of South Florida, Tampa, Florida; Professor, Department
of Epidemiology and Biostatistics, College of Public Health, University
of South Florida, Tampa, Florida; Adjunct Professor, Departments
of Biostatistics and Mental Hygiene, Bloomberg School of Public
Health, Johns Hopkins University, Baltimore, Maryland.
3 Research Fellow in Psychiatry, NIMH Post-doctoral Training in
Psychiatric Genetics, Department of Psychiatry, Harvard Medical
School, Massachusetts Mental Health Center, Harvard Institute of
Psychiatric Epidemiology and Genetics, Boston, Massachusetts.
4 Stanley Cobb Professor of Psychiatry and Head, Harvard Medical
School Department of Psychiatry at Massachusetts Mental Health Center,
Boston, Massachusetts; Director, Harvard Institute of Psychiatric
Epidemiology and Genetics, Boston, Massachusetts; Professor, Department
of Epidemiology, Harvard School of Public Health, Boston, Massachusetts;
Director, VA Cooperative Studies of Genetics of Schizophrenia, Psychiatry
Services, Brockton-West Roxbury VA Medical Center, Brockton, Massachusetts;
Clinical Associate, Harvard Medical School, Psychiatry Service,
Massachusetts General Hospital, Boston, Massachusetts.
1
| 2
| 3 | 4
| 5
|
